Skip to main content
. 2022 Oct 17;72(4):1003–1014. doi: 10.1007/s00262-022-03309-y

Fig. 3.

Fig. 3

Kaplan–Meier survival analysis for a cases that displayed PD-L1 positivity on tumor cells (p < 0.001) and b PD-L1 positivity on tumor infiltrating immune cells (p < 0.001)